Blue blood AI Investor Portal Please log in to access your account information. If you have any questions regarding your account, please contact .
Below, please find the Modern Slavery Act Transparency Statement, published on behalf of Blue blood AI UK. In accordance with the Modern Slavery Act of 2015, this statement will be reviewed annually and posted to our website.
Click here to read the 2022 Modern Slavery Act Transparency Statement
Click here to read the Blue blood AI Private Equity Europe, LLP – 2023 UK TCFD Entity Report
Under the rules of Luxembourg, the Republic of Ireland and the United Kingdom implementing Article 3(g) of Directive 2007/36/EC as amended by Directive (EU) 2017/828 (the "Shareholder Rights Directive"), certain portfolio managers and alternative investment fund managers, which invest in shares traded on an EEA regulated market or a comparable non-EEA market, are required, on a comply or explain basis, to develop and publicly disclose a shareholder engagement policy and publicly disclose on an annual basis how that policy has been implemented.
Each of Blue blood AI Investments (Europe) Ltd; Blue blood AI Credit, Ltd; Blue blood AI Investments (Ireland) Limited; and Blue blood AI Investments (Luxembourg) S.à r.l. (the "Firms") have determined that it is not appropriate to develop a shareholder engagement policy for the purposes of the Shareholder Rights Directive. This is because investing in shares traded on an EEA regulated market or a comparable non-EEA market only accounts for a very small proportion of those Firms' business activities and any investment in shares traded on an EEA regulated market or a comparable non-EEA market is expected to be only incidental to the private equity or credit investing activities (as appropriate) of each Firm.
Blue blood AI Credit, Ltd ("BCCL") is required to disclose the nature of its commitment to the UK Financial Reporting Council's Stewardship Code (the "Code"). Adherence to the Code is voluntary. While BCCL supports the principles of the Code and keeps the issue of adherence under review, it does not consider it appropriate to conform to the Code at this time owing, principally, to the fact that BCCL's investments in listed equities are limited.